SDGR
Schrödinger, Inc.
SDGR offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
UNH
UnitedHealth Group Incorporated
UNH has the edge over SDGR overall, supported by lower modeled downside and stronger modeled upside.
SDGR Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Under pressure | |
| Weak | |
| Unavailable |
SDGR's revenue is currently healthy, but its profitability and cash flow are under pressure. There isn't enough data to rate its balance sheet.
UNH Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Healthy | |
| Healthy |
UNH's cash flow and balance sheet are currently healthy, and its revenue and profitability are stable.
SDGR PE Valuation
SDGR has no meaningful PE right now: it lost money over the past year.
UNH PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 18x | $405 | — |
| Cheap | 19x | $325 | -20% |
| Fair | 23x | $410 | +1.2% |
| Current | 23x | $405 | — |
| Expensive | 30x | $526 | +30% |
Historical ranges are pointers, not guarantees.
UNH's PE is in its fair range at 23x. If earnings grow as analysts expect, today's price would be 18x next year's earnings, in its cheap range.
SDGR Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses steady | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect SDGR's profitability to improve, with its earnings and revenue holding steady. However, they disagree widely on these estimates.
UNH Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Stable | |
| Improving | |
| Moderate | |
| Low |
UNH has the edge over SDGR on the outlook, with more favorable earnings expectations.
SDGR Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$0.78 | +$1.63 |
| Q2 2026 | -$0.73 | +$1.75 |
| Q1 2026 | -$1.40 | +$1.23 |
| Q4 2025 | -$1.41 | +$1.16 |
| Q3 2025 | -$2.41 | +$0.02 |
| Q2 2025 | -$2.48 | +$0.29 |
| Q1 2025 | -$2.63 | -$0.66 |
| Q4 2024 | -$2.57 | -576% |
SDGR is still losing money, but far less than before: $0.78 per share over the past year, against $2.77 at its worst in mid-2024.
UNH Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $22.65 | +29% |
| Q3 2026 | $17.55 | -8.5% |
| Q2 2026 | $15.58 | -33% |
| Q1 2026 | $13.28 | -44% |
| Q4 2025 | $13.23 | -15% |
| Q3 2025 | $19.17 | +25% |
| Q2 2025 | $23.09 | +53% |
| Q1 2025 | $23.89 | +46% |
| Q4 2024 | $15.51 | -35% |
UNH has the edge over SDGR on earnings quality, reporting a profit while its opponent remains loss making.
SDGR Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $64.5M | +19% |
| Q2 2026 | $58.9M | +7.5% |
| Q1 2026 | $58.6M | -1.6% |
| Q4 2025 | $87.2M | -1.2% |
| Q3 2025 | $54.3M | +54% |
| Q2 2025 | $54.8M | +16% |
| Q1 2025 | $59.6M | +63% |
| Q4 2024 | $88.3M | +19% |
SDGR's revenue is recovering but still below its 2024 peak: $64M last quarter, up 19% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -41% | +44 points |
| Q2 2026 | -71% | +26 points |
| Q1 2026 | -83% | +2.2 points |
| Q4 2025 | -20% | +3.8 points |
| Q3 2025 | -85% | +109 points |
| Q2 2025 | -97% | +15 points |
| Q1 2025 | -85% | +99 points |
| Q4 2024 | -23% | +17 points |
SDGR's operating margin was −41% last quarter, up 44 points from the same quarter a year ago.
UNH Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $112.7B | -0.4% |
| Q2 2026 | $112B | +0.4% |
| Q1 2026 | $111.7B | +2% |
| Q4 2025 | $113.2B | +12% |
| Q3 2025 | $113.2B | +12% |
| Q2 2025 | $111.6B | +13% |
| Q1 2025 | $109.6B | +9.8% |
| Q4 2024 | $100.8B | +6.8% |
UNH's revenue has held roughly level: $113B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 5.8% | +2 points |
| Q2 2026 | 7.1% | +2.5 points |
| Q1 2026 | 8.1% | -0.3 points |
| Q4 2025 | 0.3% | -7.4 points |
| Q3 2025 | 3.8% | -4.8 points |
| Q2 2025 | 4.6% | -3.4 points |
| Q1 2025 | 8.3% | +0.4 points |
| Q4 2024 | 7.7% | -0.4 points |
UNH has the edge over SDGR on profitability, with a higher operating margin.
SDGR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$48.9M | +$13.5M |
| Q2 2026 | -$34.4M | +$18.1M |
| Q1 2026 | -$17.3M | -112% |
| Q4 2025 | -$16.1M | +$15.9M |
| Q3 2025 | -$62.4M | -$27.8M |
| Q2 2025 | -$52.5M | +$2.2M |
| Q1 2025 | $143.5M | +$186.8M |
| Q4 2024 | -$32M | +$7.7M |
SDGR has burned cash in almost every quarter: −$117M over the past year, against −$3M the year before.
UNH Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $4.3B | -16% |
| Q2 2026 | $10.3B | +63% |
| Q1 2026 | $8.1B | +79% |
| Q4 2025 | $160M | -89% |
| Q3 2025 | $5.1B | -61% |
| Q2 2025 | $6.3B | +6.9% |
| Q1 2025 | $4.6B | +1037% |
| Q4 2024 | $1.5B | +$7.6B |
UNH has the edge over SDGR on cash generation, producing positive trailing cash flow while its opponent burns cash.
SDGR Net Leverage
SDGR's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
UNH Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 1.7x | Healthy |
| Q2 2026 | 1.7x | Healthy |
| Q1 2026 | 2.2x | Moderate |
| Q4 2025 | 2.3x | Moderate |
| Q3 2025 | 1.7x | Healthy |
| Q2 2025 | 1.5x | Healthy |
| Q1 2025 | 1.3x | Healthy |
| Q4 2024 | 1.4x | Healthy |
UNH's net debt is about 1.7 years of its operating earnings (EBITDA), about the same as a year ago.
SDGR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 68.5 | Neutral |
| Stochastic | 75.2 | Neutral |
SDGR's weekly RSI is 69 (neutral) and its Stochastic is 75 (neutral).
UNH Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 56.4 | Neutral |
| Stochastic | 60.0 | Neutral |
UNH's weekly RSI is 56 (neutral) and its Stochastic is 60 (neutral).
SDGR PE vs Healthcare Sector
| Metric | SDGR | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
SDGR has no meaningful PE right now: it lost money over the past year.
UNH PE vs Healthcare Sector
| Metric | UNH | Sector median | Relative |
|---|---|---|---|
| PE | 23x | 26x | 11% below |
| PE % | 47 | 29 | 18 pts above |
UNH is trading at 23x earnings, a 11% discount to the Healthcare sector's median of 26x.
SDGR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $27.6 | 12% above |
| 20 week MA | $22.1 | 39% above |
| 50 week MA | $17.4 | 77% above |
| 100 week MA | $19.3 | 60% above |
| 200 week MA | $23.4 | 32% above |
SDGR has the edge over UNH on trend strength, trading above more of its moving averages.
UNH Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $394.2 | 2.8% above |
| 20 week MA | $400.5 | 1.2% above |
| 50 week MA | $361.2 | 12% above |
| 100 week MA | $376.0 | 7.8% above |
| 200 week MA | $446.6 | 9.3% below |
UNH has bounced recently, but its long-term trend is still down: it's above its 8-, 20-, 50- and 100-week averages, but 9.3% below its 200-week average.
SDGR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $31.9 | $84.0 | +163% |
| 2021 | $84.0 | $35.9 | -57% |
| 2022 | $35.9 | $18.9 | -47% |
| 2023 | $18.9 | $35.8 | +90% |
| 2024 | $35.8 | $19.8 | -45% |
| 2025 | $19.8 | $18.3 | -7.4% |
| 2026 YTD | $18.3 | $30.9 | +68% |
SDGR has the edge over UNH on returns for 2026, with the stronger performance.
UNH Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $296.0 | $340.8 | +15% |
| 2021 | $340.8 | $495.4 | +45% |
| 2022 | $495.4 | $531.3 | +7.3% |
| 2023 | $531.3 | $526.5 | -0.9% |
| 2024 | $526.5 | $510.0 | -3.1% |
| 2025 | $510.0 | $331.8 | -35% |
| 2026 YTD | $331.8 | $405.1 | +22% |
UNH has finished three years in a row lower, and it's up 22% so far in 2026.